Literature DB >> 9564459

Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.

R B Turner1, K W Weingand, C H Yeh, D W Leedy.   

Abstract

The purpose of this study was to examine the association between experimental rhinovirus infection and the elaboration of interleukin-8 (IL-8) into nasal secretions of volunteers and to determine the effect of pentoxifylline on IL-8 elaboration and rhinovirus-associated common cold symptoms. Fifty-four subjects with experimental rhinovirus infections and 20 sham-inoculated subjects were studied. Pentoxifylline had no effect on rhinovirus-induced symptoms or nasal-secretion IL-8 concentrations. IL-8 concentrations were significantly greater in nasal secretions from infected symptomatic subjects than in those from infected asymptomatic or sham-challenged subjects on days 2-4 after virus challenge. In infected subjects, there was significant rank correlation between nasal obstruction severity, rhinorrhea severity, and nasal-wash albumin concentrations and the change in IL-8 concentration from baseline on days 2-4 after virus challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564459     DOI: 10.1086/513922

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  57 in total

1.  Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans.

Authors:  Lyndsey M Muehling; Ronald B Turner; Kenneth B Brown; Paul W Wright; James T Patrie; Sampo J Lahtinen; Markus J Lehtinen; William W Kwok; Judith A Woodfolk
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

3.  Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.

Authors:  L S Zalman; M A Brothers; P S Dragovich; R Zhou; T J Prins; S T Worland; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.

Authors:  R B Turner; J A Woodfolk; L Borish; J W Steinke; J T Patrie; L M Muehling; S Lahtinen; M J Lehtinen
Journal:  Benef Microbes       Date:  2017-03-27       Impact factor: 4.205

Review 5.  Immune Responses in Rhinovirus-Induced Asthma Exacerbations.

Authors:  John W Steinke; Larry Borish
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 6.  Evolving role of leukotrienes in the pathogenesis of viral infections, including otitis media.

Authors:  Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

7. 

Authors:  A Córdova Martínez; V Del Villar Sordo
Journal:  Medicine (Madr)       Date:  2013-04-03

Review 8.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Validation of the Nasal Mucus Index, a novel measurement of acute respiratory infection severity.

Authors:  Paul M Dorresteijn; Daniel Muller; Yaoguo Xie; Zhengjun Zhang; Bruce P Barrett
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

10.  Viral upper respiratory tract infection and otitis media complication in young children.

Authors:  Tasnee Chonmaitree; Krystal Revai; James J Grady; Audra Clos; Janak A Patel; Sangeeta Nair; Jiang Fan; Kelly J Henrickson
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.